02216.HK
Broncus Holding Corporation
HKSE · Healthcare · Medical - Devices · CN
HKD 0.64
−0.78%Year over year
Reported trailing growth
- Revenue
- -60.9%
- EBITDA
- +27.1%
- EBIT
- +26.4%
- EPS
- +30.4%
- Free cash flow
- +69.6%
- Operating cash flow
- +69.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -73.6%
- EBITDA
- -19.6%
- EBIT
- -8.5%
- Net income
- -16.8%
- EPS
- -17.9%
- Free cash flow
- +2.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026